Boomerang Medical, a women-led bioelectronic medicine company, has been granted Breakthrough Device Designation from the Food and Drug Administration (FDA) for its bioelectronic technology targeting the treatment of Inflammatory Bowel Disease (IBD).
Boomerang Medical, a women-led bioelectronic medicine company, has been granted Breakthrough Device Designation from the Food and Drug Administration (FDA) for its bioelectronic technology targeting the treatment of Inflammatory Bowel Disease (IBD).